Pricing Log in Create free account
Reset Show values

Graham Defensive Investor

Large, sound companies with an unbroken dividend and earnings growth, at a modest price.

Open in screener How it works

Dividend Growth

Reliable payers with room to keep paying: a decade without a cut, a covered dividend, growing earnings.

Open in screener How it works

High Insider Buying

Companies where three or more insiders bought shares in the open market in the last three months.

Open in screener How it works

Piotroski High Score

Cheap companies whose finances are improving on eight or nine of Piotroski's nine tests.

Open in screener How it works

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 621 matches.
1 filter active
median
thirds
Free account

See all 621 matches

This screen shows only its 10 largest companies. A free account shows every match of every screen you run, and keeps one screen for you. No card.

Create free account
Powerpack

Export it, tune it, and hear when it changes

Download any screen to Excel, set your own range on any filter, and get an email the day a company enters or leaves a screen you saved.

Start 7-day free trial

Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time.

Also in Powerpack: every quarter, analyst estimates, API & MCP access. Compare plans

Table Snapshots
No.
1 VRTX Vertex Pharmaceuticals Incorporated P/E ratio for VRTX 38.20 P/S ratio for VRTX 10.47 P/B ratio for VRTX EV/EBITDA for VRTX EV/Sales for VRTX EV/FCF for VRTX P/FCF ratio for VRTX Free Cash Flow Yield for VRTX 2.86
2 MRNA Moderna, Inc. P/E ratio for MRNA (30.80) P/S ratio for MRNA 42.89 P/B ratio for MRNA EV/EBITDA for MRNA EV/Sales for MRNA EV/FCF for MRNA P/FCF ratio for MRNA Free Cash Flow Yield for MRNA 0.55
3 REGN Regeneron Pharmaceuticals, Inc. P/E ratio for REGN 15.30 P/S ratio for REGN 4.83 P/B ratio for REGN EV/EBITDA for REGN EV/Sales for REGN EV/FCF for REGN P/FCF ratio for REGN Free Cash Flow Yield for REGN 0.62
4 ARGX argenex SE P/E ratio for ARGX 30.10 P/S ratio for ARGX 8.86 P/B ratio for ARGX EV/EBITDA for ARGX EV/Sales for ARGX EV/FCF for ARGX P/FCF ratio for ARGX Free Cash Flow Yield for ARGX 0.71
5 ONC BeOne Medicines Ltd. - Sponsored ADR P/E ratio for ONC 47.70 P/S ratio for ONC 6.87 P/B ratio for ONC EV/EBITDA for ONC EV/Sales for ONC EV/FCF for ONC P/FCF ratio for ONC Free Cash Flow Yield for ONC 0.51
6 RPRX Royalty Pharma PLC P/E ratio for RPRX 27.40 P/S ratio for RPRX 8.50 P/B ratio for RPRX EV/EBITDA for RPRX EV/Sales for RPRX EV/FCF for RPRX P/FCF ratio for RPRX Free Cash Flow Yield for RPRX 1.05
7 RVMD Revolution Medicines, Inc. P/E ratio for RVMD (11.90) P/S ratio for RVMD 210.91 P/B ratio for RVMD EV/EBITDA for RVMD EV/Sales for RVMD EV/FCF for RVMD P/FCF ratio for RVMD Free Cash Flow Yield for RVMD —
8 GMAB Genmab A/S Sponsored ADR P/E ratio for GMAB 42.30 P/S ratio for GMAB 7.44 P/B ratio for GMAB EV/EBITDA for GMAB EV/Sales for GMAB EV/FCF for GMAB P/FCF ratio for GMAB Free Cash Flow Yield for GMAB 1.37
9 ROIV Roivant Sciences Ltd. P/E ratio for ROIV (29.20) P/S ratio for ROIV 490.38 P/B ratio for ROIV EV/EBITDA for ROIV EV/Sales for ROIV EV/FCF for ROIV P/FCF ratio for ROIV Free Cash Flow Yield for ROIV —
10 INCY Incyte Corporation P/E ratio for INCY 57.30 P/S ratio for INCY 4.03 P/B ratio for INCY EV/EBITDA for INCY EV/Sales for INCY EV/FCF for INCY P/FCF ratio for INCY Free Cash Flow Yield for INCY 1.38